Deepak Kilari, Anikó Szabó, Kathryn Bylow, Ariel Ann Nelson, Peter Langenstroer, Scott Johnson, Arjun Sivaraman, Kenneth Jacobsohn, Chunkit Fung, Sindhuja G Kadambi, Brian I. Rini, Melissa A Reimers, Robert S. Alter, Asit KR Paul, Brendan John Guercio, Matthew I. Milowsky. "A phase 2 study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer, (HCRN GU18-343) ABATE study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.800